The anticonvulsant action of the carbonic anhydrase inhibitor methazolamide: Possible involvement of a noradrenergic mechanism
- 30 September 1974
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 28 (1) , 42-54
- https://doi.org/10.1016/0014-2999(74)90110-1
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Comparative investigation of inhibitors of extracerebral dopa decarboxylase in man and ratsJournal of Pharmacy and Pharmacology, 1972
- L-Dopa: Effect on Concentrations of Dopamine, Norepinephrine, and Serotonin in Brains of MiceScience, 1970
- L-Dopa induced changes in central monoamine neurons after peripheral decarboxylase inhibitionJournal of Pharmacy and Pharmacology, 1970
- Decrease of cerebral 5-hydroxytryptamine by 3,4-dihydroxyphenylalanine after inhibition of extracerebral decarboxylaseJournal of Pharmacy and Pharmacology, 1968
- Carbonic anhydrase: chemistry, physiology, and inhibitionPhysiological Reviews, 1967
- Increase of Cerebral Catecholamines caused by 3,4-Dihydroxyphenylalanine after Inhibition of Peripheral DecarboxylaseNature, 1967
- Potentiation of the anticonvulsant action of acetazolamideJournal of Pharmacy and Pharmacology, 1966
- Central nervous system effects of four β-adrenergic receptor blocking agentsJournal of Pharmacy and Pharmacology, 1966
- Inhibition of decarboxylase of aromatic amino acids by 2,3,4-trihydroxybenzylhydrazine and its seryl derivativeArchives of Biochemistry and Biophysics, 1964
- A new inhibitor of decarboxylase of aromatic amino acidsCellular and Molecular Life Sciences, 1962